[Pathogenesis of transfusional iron overload and iron chelation therapy].
Ozawa
Keiya
K
D000284:Administration, Oral; D001565:Benzoates / Q000008:administration & dosage*; D015913:Chelation Therapy; D000077588:Deferasirox; D003676:Deferoxamine; D015195:Drug Design; D017707:Erythrocyte Transfusion / Q000009:adverse effects*; D006801:Humans; D007501:Iron / Q000097:blood / Q000378:metabolism; D007502:Iron Chelating Agents / Q000008:administration & dosage*; D019190:Iron Overload / Q000188:drug therapy* / Q000209:etiology*; D017410:Practice Guidelines as Topic; D014168:Transferrin / Q000378:metabolism; D014230:Triazoles / Q000008:administration & dosage*
D001565:Benzoates; D007502:Iron Chelating Agents; D014168:Transferrin; D014230:Triazoles; D007501:Iron; D003676:Deferoxamine; D000077588:Deferasirox